DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock

DanGer Shock‐like profile predicts the outcome in ST‐elevation myocardial infarction‐related cardiogenic shock

Abstract Aims The DanGer Shock (DGS) trial demonstrated that the routine use of a microaxial flow pump (mAFP) with standard care to treat STEMI‐related cardiogenic shock (STEMI‐CS) led to a lower risk of all‐cause death at 180 days than standard care alone. We investigated the impact of patient elig...

Full description

Saved in:
Bibliographic Details
Main Authors: Norman Mangner, Johannes Mierke, Dominik Baron, Felix J. Woitek, Stephan Haussig, Thomas Nowack, Ephraim B. Winzer, Julia Fischer, Robert Höllriegel, Stefanie Jellinghaus, Axel Linke
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:ESC Heart Failure
Subjects:
Cardiogenic shock
ST‐elevation myocardial infarction
Mechanical circulatory support
Microaxial flow pump
DanGer Shock
Online Access:https://doi.org/10.1002/ehf2.15269
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/ehf2.15269

Similar Items